Live feed
Filing
SC 13G/A
SC 13G/A0001104659-21-074998·D. E. SHAW & CO, L.P.
Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: 2021-05-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 540,300
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-074998
- Form type
- SC 13G/A
- Filer
- D. E. SHAW & CO, L.P.
- CIK
- CIK 1009268
- Filed
- Jun 01, 2021
- Reporting period
- May 20, 2021
- Description
- Schedule 13G beneficial ownership